trial · primary record
IM-1617
Colorectal Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2029-01 |
| Primary endpoint | Evaluate the safety and tolerability of IM-1617 in participants with unresectable locally advanced or metastatic solid tumors by incidence of adverse events (AEs) and serious adverse events (SAEs) |
| Registry ID | NCT07578571 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:33.662Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07578571
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.